Exact Sciences
EXAS
#1945
Rank
C$11.62 B
Marketcap
$62.58
Share price
-2.89%
Change (1 day)
-31.13%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -C$1.45 Billion

According to Exact Sciences's latest financial reports the company's current earnings are C$2.75 Billion. a decrease over its 2023 earnings that were of -C$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -C$1.46 Billion435.08%
2023 -C$0.28 Billion-69.28%
2022 -C$0.89 Billion-25.55%
2021 -C$1.19 Billion1.68%
2020 -C$1.17 Billion271.17%
2019 -C$0.32 Billion58.99%
2018 -C$0.2 Billion20.89%
2017 -C$0.17 Billion-30.95%
2016 -C$0.24 Billion5.09%
2015 -C$0.23 Billion57.24%
2014 -C$0.15 Billion116.53%
2013 -C$66.32 Million
2011 -C$41.29 Million143.73%
2010 -C$16.94 Million27.85%
2009 -C$13.25 Million0.27%
2008 -C$13.22 Million-20.95%
2007 -C$16.72 Million-13.53%
2006 -C$19.34 Million-10.07%
2005 -C$21.5 Million-21.81%
2004 -C$27.5 Million-33.44%
2003 -C$41.31 Million-6.51%
2002 -C$44.19 Million17.95%
2001 -C$37.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.18 Billion-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$94.36 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$36.87 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$50.09 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.37 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France